Clinical Trial Detail

NCT ID NCT04300647
Title A Study of Tiragolumab Plus Atezolizumab and Atezolizumab Monotherapy in Participants With Metastatic and/or Recurrent PD-L1-Positive Cervical Cancer (SKYSCRAPER-04)
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Hoffmann-La Roche

cervical squamous cell carcinoma

cervical adenocarcinoma

cervical adenosquamous carcinoma



Atezolizumab + MTIG7192A

Age Groups: senior adult

No variant requirements are available.